Date: 2011-02-15
Type of information: Distribution agreement
Compound: devTOX® assay
Company: CIT (France) Stemina Biomarker Discovery (USA)
Therapeutic area:
Type agreement: Collaboration
Distribution
Action mechanism:
Disease:
Details: CIT and Stemina Biomarker Discovery have entered into a strategic partnership. Under the arrangement, CIT will distribute Stemina’s devTOX® assay in Europe and will work with Stemina to validate the test for use under the REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) initiative. As early as 2012, and more particularly for volumes of one ton or more per year, REACH will require manufacturers and importers to register and test all chemicals and compositions containing chemicals.
Financial terms: Financials of the agreement were not disclosed.
Latest news:
